首页|复方丹参滴丸对老年晚期乳腺癌放化疗后患者心功能下降的保护作用

复方丹参滴丸对老年晚期乳腺癌放化疗后患者心功能下降的保护作用

扫码查看
目的 探讨复方丹参滴丸对老年晚期乳腺癌放化疗后患者心功能下降的保护作用.方法 选取2015年2月~2016年4月共150 例在本院实施老年晚期乳腺癌放化疗治疗的患者,随机均分为观察组与对照组,每组75 例.2 组患者在手术后均采用CEF 化疗[环磷酰胺(CTX)+表柔比星(EPI)+氟尿嘧啶(5FU)]方案治疗;观察组在此基础上加以复方丹参滴丸治疗.观察比较2组心功能舒张早期/舒张晚期最大血流速度(E/A)、左心室射血分数(LVEF)状况,检测2 组肌钙蛋白I(cTnI)、肌酸激酶(CK)、肌酸激酶同工酶(CK-MB)、总超氧化物歧化酶(SOD)、还原型谷胱甘肽(GSH)、丙二醛(MDA)及外周血T 淋巴细胞亚群水平,并观察2 组不良反应发生情况.结果 治疗后,观察组血清CK、CK-MB、cTnI、MDA 水平及CD8 +水平显著下降,差异有统计学意义( P<.0.05);观察组CD4+、CD4+/CD8+水平、SOD、GSH水平、E/A、LVEF指标显著增加,差异有统计学意义( P<.0.05);观察组细胞因子、T淋巴细胞亚群水平、心功能显著优于对照组,差异有统计学意义( P<.0.05).观察组不良反应(白细胞下降、脱发、恶心呕吐乏力)发生率明显低于对照组,差异有统计学意义( P<.0.05).结论 复方丹参滴丸能对老年晚期乳腺癌放化疗后患者心功能起到良好的保护作用.
Protective effect of compound Danshen dripping pill on cardiac function in elderly patients with advanced breast cancer after radiotherapy and chemotherapy
Objective To investigate the protective effect of compound Danshen dripping pill on cardiac function in elderly patients with advanced breast cancer after radiotherapy and chemotherapy.Methods 150 patients with advanced breast cancer from February 2015 to April 2016in our hospital were selected and randomly divided into observation group and control group,75 cases in each group.The patients in the two groups were treated with CEF chemotherapy(CTX+EPI+5FU),on the basis of observation group,the injection of compound Danshen dripping pill.Two groups of cardiac function E/A,LVEF status were observed and compared.The levels of cTnI,CK,CK-MB,SOD,GSH,MDA and peripheral blood T lymphocyte subsets were detected in the two groups,and observed the occurrence of adverse reactions in the two groups.Results After treatment,the serum levels of CK,MB-CK,cTnI,MDA and CD8+ were significantly decreased in the observation group,the difference was statistically significant(P<0.05),the CD4+,CD4+/CD8+,SOD,GSH,E/A,LVEF were significantly increased in the observation group,the difference was statistically significant(P<0.05).The level of cytokines and T lymphocyte subsets and cardiac function in the observation group were significantly better than those in the control group,the difference was statistically significant(P<0.05).The incidence rate of adverse reactions in the observation group(white blood cells,hair loss,nausea and vomiting)was significantlylower than that of the control group,the difference was statistically significant(P<0.05).Conclusion Compound Danshen dripping pills can protect the heart function of patients with advanced breast cancer after radiotherapy and chemotherapy.

compound Danshen dripping pilladvanced breast cancercardiac function

王琼、蒿业红、李艳霞

展开 >

浙江绿城心血管病医院 检验科,浙江 杭州 310012

萧山医院 超声科,浙江 萧山 311201

复方丹参滴丸 晚期乳腺癌 心功能

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.(4)
  • 2
  • 17